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The Budding Hemp Industry: The Effect of Texas
House Bill 1325 on Employment Drug Policies
Meina Heydari*

Contemporary attitudes toward cannabis use in the United States have shifted from War on Drugsera prohibition toward decriminalization over the past two decades. As states that do not seek to
decriminalize marijuana nonetheless enact legislation legalizing CBD, policy tensions arise. In
2019, Texas joined the ranks of states that legalized hemp and hemp-derived products with the
passage of House Bill 1325. In light of this legislation, this Article discusses the implications of
legalized cannabidiol (CBD) on employment drug policies in Texas. The benefits of CBD
legalization must be weighed against the practical implications to effectively balance policies that
aim to protect employees and employers with potentially divergent interests. This Article examines
the various sources of employment protection in Texas and advocates for an amendment to H.B
1325 that raises the threshold of delta-9 tetrahydrocannabidiol (THC) content permitted in hemp,
an adoption of administrative rules modeled after those established by the Utah Department of
Agriculture and Food, and an amendment to the Texas Labor Code. This approach places the
burden on CBD sellers to verify that their products are consistent with claimed CBD content,
ensures that the products produce no psychoactive effects, allows room for error in the event of
inconsistent THC content, and protects individuals who are mistakenly deemed as using illegal
drugs.

*
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I. Introduction
Seventy-two-year-old Lena Bartula takes cannabidiol (CBD) to treat pain caused by her sciatica.1
On September 16, 2018, she passed through Texas during her trip from Mexico to Portland, Oregon
to visit her granddaughter.2 At DFW Airport, however, police arrested her when a bag check at
the customs checkpoint yielded the discovery of her CBD oil.3 Testing instruments could not
differentiate between CBD and tetrahydrocannabidiol (THC), and she was charged with
possession of a controlled substance.4 Bartula was booked, fingerprinted, given a tuberculosis
vaccine shot without her consent, and jailed for two days at the Tarrant County Jail.5 Although
she was released, Bartula’s case was not dismissed until two months later, when a grand jury
declined to indict her.6
As CBD use skyrockets,7 consumers like Bartula must contend with possible criminal
implications. However, Bartula’s case highlights another aspect of life that may be affected:
employment. While CBD is now legal at both the federal and state levels, consumers face
occupational ramifications if they test positive for THC, even if they have never used marijuana.8
Due to CBD’s relatively new presence in the market, the Federal Drug Administration (FDA) has
yet to develop standards and regulations governing the content of CBD products.9 The Texas
government lacks the requisite testing equipment to ascertain whether CBD products satisfy the
statutorily required THC threshold.10 Remedies under the Americans with Disabilities Act (ADA)
and Texas Labor Code are unavailable due to the alleged use of illegal drugs.11 The recent
legalization of CBD, therefore, allowed consumers access to a whole new market, but failed to
implement policies to ensure their safety. Instead, Texas consumers face onerous consequences
without ever breaking the law.
1

Carlos Miller, Stop Arresting Grandmothers for CBD, MIAMI NEW TIMES (May 28, 2019),
https://www.miaminewtimes.com/marijuana/stop-cbd-cannabidol-marijuana-arrests-of-grandmothers-hesterburkhalter-and-lena-bartula-11181105.
2
Id.; Mitch Mitchell, Still Illegal: Texas Law on CBD Oil Lands Grandmother in Jail After DFW Airport Search,
FORT WORTH STAR-TELEGRAM (May 22, 2019), https://www.star-telegram.com/news/local/article230704704.html.
3
Mitchell, supra note 2.
4
Miller, supra note 1.
5
Mitchell, supra note 2.
6
Id.
7
Matej Mikulic, Total U.S. Cannabidiol (CBD) Consumer Sales from 2014 to 2022, STATISTA (Sept. 2018),
https://www.statista.com/statistics/760498/total-us-cbd-sales/ (last updated Sept. 23, 2020).
8
See Horn v. Medical Marijuana, Inc., 383 F. Supp. 3d 114, 121–22 (W.D.N.Y. 2019).
9
See generally Press Release, U.S. Food & Drug Admin., FDA Approves First Drug Comprised of an Active
Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy, (June 25, 2018),
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredientderived-marijuana-treat-rare-severe-forms.
10
See Nicholas Bogel-Burroughs, Texas Legalized Hemp, Not Marijuana, Governor Insists as Prosecutors Drop Pot
Charges, N.Y. TIMES (July 19, 2019), https://www.nytimes.com/2019/07/19/us/texas-hemp-marijuanalegalization.html.
11
See 42 U.S.C.A. § 12114(a)–(b) (West 2009); TEX. LAB. CODE ANN. § 21.051 (West 2019).
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The goal of this Article is to analyze the scientific differences between marijuana and hemp,
examine the formation of the legal definition of the substances, apply the existing employment
protection structures to the recent legislation, and ultimately suggest a change in policy for state
governments that have not legalized marijuana to implement in the future. Part II of this Article
will clarify the differences between marijuana, hemp, and CBD and will provide context for
lawmakers’ decision to legalize hemp and CBD. Part III will provide a historical background of
the cannabis decriminalization processes in the United States to highlight how many states are
further ahead of the curve regarding cannabis regulation.
Then, Part IV of this Article will examine the current difficulty differentiating between marijuana
and hemp from the perspectives of law enforcement and employers. Part V will analyze the
interaction between cannabis use and employment discrimination protection and the effect of CBD
legalization on the existing structure. A brief discussion of the ADA and the Texas Labor Code is
necessary to understand the effect of marijuana use on the ability to implicate the statutory
protections. This section will also assess the lack of regulation of CBD products, the FDA’s
current regulatory position regarding the presence of CBD products in interstate commerce, and
possible protections under federal and state employment discrimination laws for users of CBD
who may test positive for THC.
Lastly, Part VI will propose a three-pronged amendment to Texas House Bill 1325: an increase of
the THC threshold, the enactment of administrative rules by the Texas Department of Health
mandating third-party verification of CBD products and state-allocated funding for enforcement,
and an exception to the Texas Labor Code protecting individuals who disprove allegations of
illegal drug use. The proposed amendment provides a balance of interests that benefits both the
economic and individual well-being of Texas citizens following the passage of H.B. 1325.

II. Definitions of Marijuana, Hemp, & CBD
There is confusion regarding the difference between hemp and marijuana, and how CBD factors
into the equation.12 However, understanding those differences is the key to forming a practical
employment policy regarding the use of CBD.
Marijuana and hemp are two members of the cannabis genus.13 This species of plant produces a
variety of chemical compounds known as cannabinoids.14 While the plant produces many different
cannabinoids, the two relevant to this discussion are delta-9 tetrahydrocannabidiol and
cannabidiol.15 Delta-9 tetrahydrocannabidiol, more commonly known as THC, is the cannabinoid
12
See generally Peter Grinspoon, Cannabidiol (CBD) – What We Know and What We Don’t, HARV. HEALTH
PUBL’G: HARV. HEALTH BLOG (Aug. 24, 2018, 6:30 AM), https://www.health.harvard.edu/blog/cannabidiol-cbdwhat-we-know-and-what-we-dont-2018082414476.
13
DAVID P. WEST, N. AM. INDUS. HEMP COUNCIL, HEMP & MARIJUANA: MYTHS & REALITIES 3 (1998).
14
See id. at 7.
15
See id. See generally Ernest Small, Evolution and Classification of Cannabis Sativa (Marijuana, Hemp) in
Relation to Human Utilization, 81 BOTANICAL REV. 3, 189, 240–41 (Aug. 2015).
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responsible for inducing the psychoactive effect, or the notorious “high.”16 The cannabis plant
must contain at least one percent THC in order to produce the psychoactive effect.17 Cannabidiol,
commonly referred to as CBD, is a non-intoxicating cannabinoid that has been shown to reduce
the effects of THC.18 A substance containing a high amount of CBD will thus be incapable of
producing the “high” that marijuana is known for.19 Instead, scientific studies indicate that CBD
produces anti-inflammatory and neuroprotective effects.20
Marijuana is depicted frequently in the media and is likely the most recognizable recreational drug
to the public.21 There are various stages of cultivation and an abundance of concentrated
products.22 The typical method of consumption involves combustion or vaporization of a cured
flower end product that generally contains anywhere from 3.4% to 20% THC, and cannabis oils
can contain as much as eighty percent THC.23 Hemp itself, referred to as “industrial hemp,” is the
cannabis plant that has been cultivated to contain low amounts of THC and high amounts of
CBD.24
Put simply, marijuana and hemp are cousins in the cannabis genus and contain varying amounts
of CBD and THC, with hemp containing more CBD than THC.25 Congress has defined “hemp”
as the cannabis sativa plant that contains less than 0.3% THC on a dry-weight basis.26 A plant
that contains 0.31% THC on a dry-weight basis, therefore, is legally classified as a marijuana plant,
regardless of the fact that it does not produce marijuana’s psychoactive effect.27 In other words,
Congress imposed definitions on naturally occurring plant products—a decision that seems
somewhat laughable in light of the current tensions with respect to the differences between the two
plants. Hemp may be used in a multitude of products, such as fertilizer, cosmetics, cooking oils,
paints, and automotive fuel.28 Its pervasiveness in the market, therefore, sets consumers up to face
the issue of testing due to the heightened risk of inadvertently ingesting THC.

16

WEST, supra note 13, at 7–8.
Small, supra note 15, at 242.
18
WEST, supra note 13, at 7–8.
19
See id at 8.
20
Lawrence Leung, Cannabis and Its Derivatives: Review of Medical Use, 24. J. AM. BD. FAM. MED. 452, 458–59
(July 2011).
21
See Steve P. Calandrillo & Katelyn Fulton, “High” Standards: The Wave of Marijuana Legalization Sweeping
America Ignores the Hidden Risks of Edibles, 80 OHIO ST. L.J. 201, 203 (2019).
22
See Paul J. Larkin, Jr., Marijuana Edibles and “Gummy Bears”, 66 BUFF. L. REV. 313, 318 (Apr. 2018).
23
See id. at 318, 338.
24
See WEST, supra note 13, at 8.
25
See id.; Grinspoon, supra note 12.
26
7 U.S.C.A. § 1639o(1) (West 2018).
27
See Nicole Gleichmann, Hemp vs. Marijuana: Is There a Difference?, ANALYTICAL CANNABIS (Sept. 2, 2019),
https://www.analyticalcannabis.com/articles/hemp-vs-marijuana-is-there-a-difference-311880.
28
See DAVID G. KRAENZEL ET AL., INDUSTRIAL HEMP AS AN ALTERNATIVE CROP IN NORTH DAKOTA 7 fig.2 (Agric.
Econs. Report No. 402, 1998).
17
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The Texas Legislature has designated CBD products marketed for individual use as consumable
hemp products.29 CBD products may be labeled as one of three types: full-spectrum CBD, broadspectrum CBD, or CBD isolate.30 In full-spectrum CBD, all of the naturally occurring compounds
in the cannabis plant are present, including terpenes, flavonoids, and THC.31 Such extracts are
required to contain less than 0.3% THC, but compliance is difficult to ascertain due to the lack of
available testing.32 Full-spectrum CBD is widely available.33 The second type of product is broadspectrum CBD, which is essentially full-spectrum CBD without THC.34 This type of CBD extract
is less available than full-spectrum CBD.35 The third type of CBD product is CBD isolate, or pure
CBD.36 It does not contain THC or any other compounds and is generally derived from the hemp
plant itself.37 CBD isolate is typically sold as an oil, tincture, edible slab, or crystalline powder.38
CBD and marijuana both take a variety of similar forms, and uninformed consumers may be unable
to distinguish between them in order to comply with the law.

III. History of Cannabis Decriminalization
Having established the substantive differences between marijuana, hemp, and CBD, this Article
next describes the historical background of the cannabis decriminalization processes in the United
States, beginning with marijuana. Had the legislative bodies considered this history, they may
have been able to foresee, and thus prevent, the issues that have arisen.
It is important to note, however, the difference between the terms “decriminalization” and
“legalization.” Decriminalization refers to “policies that do not define possession for personal use
or casual distribution as criminal offenses.”39 For example, marijuana is decriminalized in
Mississippi because a first-time offense of possession of fewer than thirty grams of marijuana is
punishable by a $250 fine.40 Legalization, on the other hand, “removes the criminal and monetary

29

See H.R. 1325, 86th Leg., Reg. Sess. (Tex. 2019).
Alan Carter & Carly Vandergriendt, Does CBD Show Up on a Drug Test?, HEALTHLINE (Apr. 24, 2019),
https://www.healthline.com/health/does-cbd-show-up-on-a-drug-test.
31
Id. Terpenes are naturally occurring compounds that provide cannabis with its distinct scent. Flavonoids are
metabolites that affect UV filtration, pigmentation, and nitrogen fixation. Sean M. O’Connor & Erika Lietzan, The
Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling, 68 Am. U. L. Rev. 823, 848 (2019).
32
Carter & Vandergriendt, supra note 30.
33
Id. See also Jessica Timmons, Best-Full-Spectrum CBD Oils, HEALTHLINE (Oct. 27, 2020),
https://www.healthline.com/health/best-full-spectrum-cbd-oil; 10 Best Full Spectrum CBD Oil, BEST CBD,
https://www.bestcbdoils.org/best-full-spectrum-cbd-oil/ (last visited Nov. 11, 2020). As the most widely available
form of CBD, full-spectrum CBD implicates a higher likelihood that consumers will inadvertently ingest more THC
than they believe.
34
Id.
35
Id.
36
Id.
37
Id.
38
Id.
39
Rosalie Liccardo Pacula & Rosanna Smart, Medical Marijuana and Marijuana Legalization, 13 ANN. REV.
CLINICAL PSYCHOL. 397, 400 (2017).
40
Mississippi, MARIJUANA POL’Y PROJECT, https://www.mpp.org/states/mississippi/ (last updated Oct. 4, 2020).
30
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penalties for the possession, use, and supply of marijuana for recreational purposes.”41 For
example, marijuana is legalized in fifteen states and the District of Columbia, wherein citizens
may freely purchase and consume marijuana.42 In other words, legalization and decriminalization
may be viewed as a hierarchy in which legalization renders decriminalization unnecessary.

A. Marijuana
Congress significantly acted upon the issue of marijuana for the first time in 1937 when it passed
the Marihuana Tax Act.43 While the Act did not declare the drug illegal, it implemented various
requirements and taxes that paralyzed the marijuana industry.44 In 1970, Congress acted again by
repealing the Marihuana Tax Act and replacing it with the Comprehensive Drug Prevention and
Control Act, which effectively declared all cannabis illegal—regardless of whether it was
marijuana or hemp.45 Title II of the Act, known as the Controlled Substances Act (CSA), contains
five categories, or schedules, in which substances may be placed.46 Congress categorized
substances based on possibility of abuse, accepted medical use in treatment, and degree of
dependence.47 Upon its enactment, the CSA classified marijuana as a Schedule I drug.48 A drug
or substance placed in Schedule I has a high possibility for abuse and lacks both any “currently
accepted medical use in treatment in the United States” and “accepted safety for use under medical
supervision.”49 This framework relies on legislative action; it lacks a self-updating mechanism to
reschedule drugs, resulting in laws that lag behind accepted medical uses, particularly in light of
severe restrictions on marijuana research.50
In the same year that Congress enacted the CSA, President Richard Nixon announced a national
“war on drugs.”51 In 1972, he appointed the National Commission on Marihuana and Drug Abuse,
known colloquially as the Shafer Commission, to study the health and psychological effects of
marijuana.52 After analyzing the interrelationships between marijuana use, marijuana itself, and
41

Pacula & Smart, supra note 39, at 401.
Darla Mercado, These 4 States are Voting to Legalize and Tax Marijuana Sales, CNBC, (Oct. 7, 2020),
https://www.cnbc.com/2020/10/07/f04-states-voting-to-puff-puff-pass-pot-legalization.html. See also Kyle Jaeger,
Every Single Marijuana and Drug Policy Ballot Measure Passing on Election Day Bolsters Federal Reform,
MARIJUANA MOMENT (Nov. 4, 2020), https://www.marijuanamoment.net/every-single-marijuana-and-drug-policyballot-measure-passing-on-election-day-bolsters-federal-reform-push/.
43
See generally WEST, supra note 13, at 9–10 (discussing the history of the Marihuana Tax Act).
44
See Gonzales v. Raich, 545 U.S. 1, 11 (2005) (“the onerous administrative requirements, the prohibitively
expensive taxes, and the risks attendant on compliance practically curtailed the marijuana trade.”).
45
WEST, supra note 13, at 10–11.
46
21 U.S.C.A. § 812(b) (West 2018).
47
See id.
48
Id. § 812(c).
49
Id. § 812(b).
50
See generally 21 C.F.R. § 1301.18 (2010) (stating protocols for research with Schedule I substances).
51
Raich, 545 U.S. at 10.
52
See NAT. COMM’N ON MARIJUANA AND DRUG ABUSE, MARIJUANA: A SIGNAL OF MISUNDERSTANDING (1972),
http://www.druglibrary.org/schaffer/library/studies/nc/ncmenu.htm.
42
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marijuana as a social problem, the Commission recommended decriminalization of marijuana,
finding that criminalization of possession for personal use [was] socially self-defeating.53
However, President Nixon rejected the findings.54
Marijuana is still today prohibited as a Schedule I controlled substance pursuant to federal law.55
However, fifteen states and the District of Columbia have legalized recreational marijuana use,56
and thirty-six have enacted some form of compassionate use legislation.57 The conflict between
federal and state legality—or lack thereof—has led to confusion as to whether states that have
legalized or decriminalized marijuana must enforce the federal policy prohibiting it.58 A widely
accepted concept of voluntary cooperation has formed in the wake of such uncertainty; states may
choose whether to accept the federal invitation, created through the CSA, to authorize their own
officers to arrest for a violation of the federal marijuana policy.59
However, the Trump administration has radically affected the concept of voluntary cooperation.60
In 2009, then-Deputy Attorney General David Ogden issued a memorandum informing federal
prosecutors that prosecution of individuals lawfully using marijuana for serious illnesses was an
inefficient use of resources.61 Former Deputy Attorney General James M. Cole followed up with
a memorandum in 2013, allowing states to enforce their own decriminalization structures and
advising law enforcement to enforce the CSA only when the use, possession, or distribution of
marijuana threatened to cause harm specified in the memorandum.62 However, under the Trump
administration, Attorney General Jeff Sessions rescinded all previous guidance and effectively
mandated federal law enforcement to enforce the CSA against all marijuana use, regardless of
whether a state has adopted the decriminalization structure.63
In 2019, House and Senate members in the 116th Congress introduced a number of bills proposing
changes in marijuana policy.64 H.R. 2093, also known as the Strengthening the Tenth Amendment
53

Id. at ch. 5; see Michael Vitiello, Legalizing Marijuana and Abating Environmental Harm: An Overblown
Promise?, 50 U.C. DAVIS L. REV. 773, 784 (Dec. 2016).
54
EMILY DUFTON, GRASS ROOTS: THE RISE AND FALL AND RISE OF MARIJUANA IN AMERICA, 54 (2017).
55
21 U.S.C.A. § 812(c)(1) (West 2018).
56
Mercado, supra note 42.
57
Katherine Berger, ABCs and CBD: Why Children with Treatment-Resistant Conditions Should Be Able to Take
Physician-Recommended Medical Marijuana at School, 80 OHIO ST. L.J. 309, 324 (2019). See also State Medical
Marijuana Laws, NAT. CON. STATE LEGS., https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
(last visited Nov. 11, 2020).
58
See generally Callaghan v. Darlington Fabrics Corp., No. PC-2014-5680, 2017 WL 2321181, at *13–*15 (R.I.
Super. May 23, 2017) (discussing preemption).
59
See Todd Grabarsky, Conflicting Federal and State Medical Marijuana Policies: A Threat to Cooperative
Federal, 116 W. VA. L. REV. 1, 18 (2013).
60
See Memorandum from Att’y Gen. Jefferson B. Sessions to U.S. Att’ys (Jan. 4, 2018), https://www.justice.gov/op
a/press-release/file/1022196/download.
61
Memorandum from Deputy Att’y Gen. David W. Ogden to Selected U.S. Att’ys (Oct. 19, 2009), https://www.justi
ce.gov/opa/press-release/file/1022196/download.
62
Memorandum from Deputy Att’y Gen. James M. Cole to U.S. Att’ys (Aug. 29, 2013), https://www.justice.gov/iso
/opa/resources/3052013829132756857467.pdf.
63
Memorandum from Att’y Gen. Jefferson B. Sessions to U.S. Att’ys, supra note 60.
64
See H.R. 2093, 116th Cong. (2019); H.R. 127, 116th Cong. (2019).
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Through Entrusting States (STATES) Act, proposes an amendment to the CSA that protects states’
ability to enact marijuana policies.65 Similarly, the House has introduced H.R. 127.66 This
bipartisan act, known as the Compassionate Access, Research Expansion, and Respect States
(CARERS) Act of 2019, proposes “[t]o extend the principle of federalism to state drug policy,
provide access to medical marijuana, and enable research into the medicinal properties of
marijuana.”67 While the current federal policy regarding marijuana is a clear prohibition, the
matter is becoming a nationally recognized issue with support from both major parties.68
Therefore, it remains to be seen as to whether that policy will change.
Prior to 1996, all fifty states prohibited marijuana.69 In 1996, however, California became the first
state to decriminalize marijuana for medical use.70 Alaska, Oregon, and Washington did the same
in 1998.71 Over the next ten years, ten states decriminalized medical marijuana.72 In 2012,
Colorado made history as the first state to legalize recreational marijuana.73 As of 2020, thirtyfour states have decriminalized marijuana for medicinal use.74 Alaska, Arizona, California,
Colorado, Illinois, Maine, Massachusetts, Michigan, Mississippi, Montana, Nevada, New Jersey,
Oregon, South Dakota, Washington, Vermont, and the District of Columbia have legalized
marijuana for both medical and recreational use.75
Texas is one state that has yet to decriminalize marijuana.76 However, the Texas Legislature
implemented the Compassionate Use Act in 2015.77 This bill allows registered physicians to

65

H.R. 2093.
H.R. 127.
67
Id.; accord Press Release, Cong. Steve Cohen, Lawmakers Introduce Bipartisan Med. Marijuana Bill (Jan. 3,
2019), https://cohen.house.gov/media-center/press-releases/lawmakers-introduce-bipartisan-medical-marijuana-bill.
68
Andrew Daniller, Two-Thirds of Americans Support Marijuana Legalization, PEW RESEARCH CTR. (Nov. 14,
2019), https://www.pewresearch.org/fact-tank/2019/11/14/americans-support-marijuana-legalization/.
69
Alex Kreit, Marijuana Legalization and Nosy Neighbor States, 58 B.C. L. REV. 1059, 1059 (2017).
70
Calandrillo & Fulton, supra note 21, at 210.
71
Id. at 211–13 tbl. 1.
72
Id.
73
See id. (showing that Washington also legalized recreational marijuana in the same year).
74
Id. at 210; Jaeger, supra note 42.
75
Id. at 210; CBS NEWS & ASSOCD. PRESS, Illinois Becomes 11th State to Legalize Recreational Marijuana, CBS
NEWS (June 25, 2019, 2:05 PM), https://www.cbsnews.com/news/illinois-recreational-marijuana-governor-legalizesgovernor-j-b-pritzker-signs-bill-today-2019-06-25/. See also Kyle Jaeger, Every Single Marijuana And Drug Policy
Ballot Measure Passing On Election Day Bolsters Federal Reform, MARIJUANA MOMENT (Nov. 4, 2020),
https://www.marijuanamoment.net/every-single-marijuana-and-drug-policy-ballot-measure-passing-on-electionday-bolsters-federal-reform-push/.
76
See Mercado, supra note 42. As of November 10, 2020, Texas legislators have pre-filed fifteen bills related to the
decriminalization and legalization of marijuana. Tracking: Texas Marijuana Policy, 87th Legislative Session,
TEXANS FOR RESPONSIBLE MARIJUANA POLICY,
http://www.texasmarijuanapolicy.org/txmj21/?fbclid=IwAR2R3tXTHELUwbTVxZb7Dyy-307KsHnl5mJHuEP2ScJ68nGwib7HjqgZsQ (last visited Nov. 11, 2020).
77
See Texas Compassionate Use Act of 2015 § 4, TEX. OCC. CODE ANN. §§ 169.001–169.005 (West 2019).
66
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prescribe cannabis containing low percentages of THC to patients suffering from epilepsy.78 The
Act defines low-THC cannabis as containing less than 0.5% THC on a dry-weight basis.79 House
Bill 3703, enacted in 2019, expands the application of the Compassionate Use Act to additional
medical disorders.80 “Incurable neurodegenerative disease, terminal cancer, a seizure disorder,
multiple sclerosis, spasticity, amyotrophic lateral sclerosis, and autism” now qualify as covered
medical disorders.81 Thus, Texas allows the use of low-THC marijuana in specified
circumstances.82

B. Hemp
Along with marijuana, the 1937 Marihuana Tax Act banned hemp from the United States
markets.83 In 1970, the CSA included hemp as an illegal substance and was subsequently
reinforced by the Drug Enforcement Agency’s (DEA) interpretation of its language.84 The CSA
classified “any material, compound, mixture, or preparation, which contains . . . THC” as a
Schedule I controlled substance.85 However, it simultaneously excluded “mature stalks of
[Cannabis sativa] plant” from its definition of marijuana.86 The DEA, utilizing its regulatory
authority, interpreted the former language to include hemp as a Schedule I substance.87 Therefore,
the government had prohibited all forms of cannabis pursuant to the CSA until the passage of the
2018 Farm Bill.88
Before the 2018 Farm Bill, the 2014 Farm Bill served as the first move away from hemp
prohibition pursuant to federal law.89 The bill instituted an exception for hemp production by
allowing farmers to grow hemp under specified conditions.90 It established a definition of hemp
and narrowly allowed its production; however, hemp was still categorized as a Schedule I drug,
along with all other forms of cannabis.91 The bill enacted a form of protection for hemp growers
in the Hemp Pilot Programs, which allowed those who registered under a state’s hemp research
program to cultivate the plant.92 Nevertheless, hemp remained illegal if produced in violation of
the Farm Bill’s requirements.93
78

TEX. OCC. CODE ANN. § 169.003(3)(A)(i).
Id. § 169.001(3).
80
Id. § 169.003.
81
Id.
82
See id.
83
Shannon Smith, Hemp on the Horizon: The 2018 Farm Bill and the Future of CBD, 98 N.C.L. REV. ADDENDUM
35, 40 (2020).
84
Id. at 41.
85
Id.
86
Id.
87
See id.
88
See id. at 41–42.
89
Id. at 42.
90
Agricultural Act of 2014, Pub. L. No. 133-79, § 7606, 128 Stat. 649, 912-13 (codified as amended at 7 U.S.C.
§ 5940 (2018)).
91
Id.; Smith, supra note 83, at 42.
92
Id.
93
Id.
79
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The 2018 Farm Bill expanded the realm of hemp cultivation established by the 2014 Farm Bill.94
It defined industrial hemp as cannabis containing 0.3% THC on a dry-weight basis,95 adopted from
a Canadian scientific study that sought to differentiate between two strains of marijuana.96 The
researchers themselves had “arbitrarily adopt[ed] a concentration of 0.3% THC . . . as a guide to
discriminating [between hemp and marijuana]” during the study.97 Additionally, the bill legalized
hemp production across the board and declassified it as a Schedule I drug.98 It established a federal
framework for hemp regulation and enforcement by transferring the regulatory authority to the
U.S. Department of Agriculture.99 However, while the 2018 Farm Bill removed hemp from
Schedule I status, it did not federally legalize CBD.100 Instead, CBD is legal if, and only if, the
hemp from which it is derived complies with federal and state regulations and is produced by a
licensed cultivator.101 If the hemp in question does not comply with such requirements, the CBD
product is deemed a Schedule I drug.102
In 2019, the Texas Legislature approved the passage of House Bill 1325.103 The bill legalized the
use and production of hemp and hemp-derived products, such as CBD oil, and mirrored the federal
statute in defining hemp.104 The Texas Legislature had previously emphasized that it had no
intention of decriminalizing marijuana;105 H.B. 1325 pertains exclusively to hemp and hempderived products.106

IV. Lack of Proper Testing
When H.B. 1325 legalized hemp and its derivatives, it created challenges in differentiating
between hemp and marijuana. Such challenges carry implications in both criminal and
employment contexts. This Part explores how law enforcement and employers must contend with
these difficulties following the bill’s enactment.
94

See id.
Agricultural Improvement Act of 2018 § 297A, 7 U.S.C. § 1639o (2018).
96
See Ernest Small & Arthur Cronquist, A Practical and Natural Taxonomy for Cannabis, 25 TAXON 4, 405, 408
(Aug. 1976).
97
Id.
98
Agricultural Improvement Act § 12619.
99
See Smith, supra note 83, at 42.
100
Berger, supra note 57, at 324.
101
John Hudak, The Farm Bill, Hemp Legalization and the Status of CBD: An Explainer, BROOKINGS INST. (Dec.
14, 2018), https://www.brookings.edu/blog/fixgov/2018/12/14/the-farm-bill-hemp-and-cbd-explainer/.
102
Id.
103
See generally H.R. 1325, 86th Leg., Reg. Sess. (Tex. 2019).
104
See id.; 7 U.S.C. § 1639o(1) (2018).
105
On November 10, 2020, Texas legislators pre-filed three proposals to legalize marijuana. See HJR 13, 87th Leg.
Reg., Reg. Sess. (Tex. 2020); S.B. 14087th Leg. Reg., Reg. Sess. (Tex. 2020); H.B. 447, 87th Leg., Reg. Sess. (Tex.
2020).
106
See Letter from Greg Abbott, Governor of Tex., et al., to Tex. Dist. And Cty. Att’ys, (July 18, 2019).
95
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A. Law Enforcement
While advocates have lauded H.B. 1325 as a step forward for both agricultural and legalization
interests, it has simultaneously created confusion with respect to enforcement.107 Prior to the
passage of the bill, the marijuana testing process simply consisted of identifying hairs on marijuana
flowers and using a cannabinoid-detecting test strip.108 However, crime laboratories must now
establish the precise percentage of THC in the suspected substance to determine whether it is
marijuana or hemp.109 Prosecutors and forensic experts have raised concerns that public
laboratories lack the proper testing equipment while well-equipped laboratories impose high
costs.110 In fact, the president of the Houston Forensic Science Center has identified only two
laboratories in the nation with such capabilities, and both are privately owned.111
Texas law enforcement now faces both financial and practical implications of the bill. Prosecutors
must contend with the possibility that they may be required to compensate the aforementioned
private labs to run the tests and testify to the results at trial.112 Given that marijuana offenses made
up twenty-four percent of the Texas criminal docket in 2018, the potential financial impact on the
state is staggering.113 Practically, there is a potential for tremendous backlogging of marijuana
cases.114 In 2018, marijuana-related arrests in the United States totaled 663,367.115 In Texas
specifically, the criminal docket contained 113,452 active marijuana possession cases.116
Considering these numbers, it is unrealistic to expect two crime labs to handle marijuana testing
for the entire state of Texas, particularly when accounting for other states that have not
decriminalized marijuana.117
Prosecutors across Texas have voiced such concerns, with many having dropped misdemeanor and
even felony possession charges.118 Prosecutors fear that the bill has eliminated the possibility of
using circumstantial evidence: law enforcement can no longer rely on using the smell and

107

See Bogel-Burroughs, supra note 10.
Id.
109
Id.
110
Id.
111
Id.
112
Id.
113
Off. Of Court Admin., Annual Statistical Report for the Texas Judiciary: Fiscal Year 2018, TEX. JUD. COUNCIL,
1, 31 https://www.txcourts.gov/media/1443455/2018-ar-statistical-final.pdf (last visited Oct. 26, 2020).
114
Bogel-Burroughs, supra note 10.
115
See Uniform Crime Reporting, 2018 Crime in the United States, FBI, https://ucr.fbi.gov/crime-in-theu.s/2018/crime-in-the-u.s.-2018/topic-pages/persons-arrested (last visited Oct. 26, 2020) (stating that, of 1,654,282
drug-related arrests, 3.3% were related to sale/manufacturing of marijuana and 36.8% were related to marijuana
possession).
116
Off. Of Court Admin., supra note 113, at 18.
117
See generally Bogel-Burroughs, supra note 10 (stating that there are only two accredited labs in Texas that can
appropriately distinguish between marijuana and hemp).
118
Id.
108
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appearance of marijuana as evidence because hemp has similar characteristics.119 The primary
distinction between marijuana and hemp lies in the THC concentration; an inability to test this
difference may hinder the conclusion that a suspected substance is marijuana “beyond a reasonable
doubt.”120
In response to such dismissals and concerns, Texas Governor Greg Abbott, Lieutenant Governor
Dan Patrick, Speaker of the Texas House of Representatives Dennis Bonnen, and Texas Attorney
General Ken Paxton issued a letter to Texas district and county attorneys.121 It stated that attorneys
have misunderstood H.B. 1325 and advised them that lab tests are not the exclusive method of
proving marijuana possession cases.122 It went on to emphasize the acceptability of circumstantial
evidence.123 Additionally, the letter stated that companies and labs were developing THC
concentration tests prior to the passage of H.B. 1325, and that costs of THC tests would decline as
companies enter the market for testing.124 The letter reminded attorneys that marijuana remained
illegal and that they were responsible for carrying out the law.125
Some Texas counties have proceeded to charge and prosecute marijuana cases as they had done
prior to the adoption of the bill.126 However, district attorneys in Travis and Harris counties have
reaffirmed their plans to require lab testing for low-level marijuana cases in order to prove guilt
beyond a reasonable doubt.127 Until labs possess the requisite testing equipment to determine THC
concentration levels, many prosecutors are postponing prosecution of marijuana offenses as
advised by the Texas District and County Attorneys Association.128 Until Texas can establish a
consistent method of discerning THC concentration levels, such confusion will likely continue.129

119

See id. See generally Big Sky Scientific LLC v. Idaho State Police, No. 1:19-cv-00040-REB, 2019 WL 438336 at
*3 (D. Idaho Feb. 2, 2019) (describing a defendant who was arrested while transporting 7,000 pounds of industrial
hemp and charged with marijuana trafficking).
120
See generally Bogel-Burroughs, supra note 10 (stating that labs are now required to determine the concentration
of THC in seized substances due to the new legal distinction between marijuana and hemp).
121
Letter from Greg Abbott, Governor of Tex., et al., to Tex. Dist. And Cty. Att’ys, supra note 106.
122
Id.
123
Id.
124
Id.
125
Id.
126
Jolie McCullough & Alex Samuels, This Year, Texas Passed a Law Legalizing Hemp. It Also Has Prosecutors
Dropping Hundreds of Marijuana Cases, TEX. TRIBUNE (July 3, 2019), https://www.texastribune.org/2019/07/03/te
xas-marijuana-hemp-testing-prosecution/.
127
Id.
128
Interim Update: Hemp, TEX. DIST. & CTY. ATT’YS ASS’N (June 24, 2019),
https://www.tdcaa.com/legislative/interm-update-hemp/.
129
See generally Boulette Golden & Marin LLP, Changing Laws, Attitudes Pushing Employers to Explore
Alternatives to Drug Tests, 30 NO. 11 TEX. EMP. L. LETTER 4 (Nov. 2019).
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B. Employers
A 2018 study found that Dallas and Houston were among the top ten cities in the nation with the
highest amount of jobs that require drug testing.130 Texas employers are likely to encounter
comparable levels of difficulty in determining whether employees are using marijuana or CBD
solely on the basis of drug test results.131 The current inability to test CBD creates tension between
permitted state use and employers’ ability to regulate the conduct of their employees inside and
outside the workplace.
Urinalysis testing is one of the most common methods used in the workplace.132 However, such
tests merely establish drug use and cannot indicate levels of intoxication.133 In fact, research
indicates that unintentional inhalation of marijuana smoke may be sufficient to trigger a positive
urinalysis test result.134 The existing unreliability of drug testing methods faces compounded
uncertainty in light of H.B. 1325.135 In addition, employers have given no indication that they
intend to change their existing testing procedures.136
Therefore, employers now must contend with drug testing employees and establishing whether
positive test results are due to marijuana or CBD use.137 For example, a former federal agent in
Texas failed a drug test that returned a positive result for marijuana despite the fact that he had
used CBD oil, not recreational marijuana, to alleviate back pain.138 Conventional drug testing
methods are able to detect the presence of THC but cannot differentiate between marijuana and
CBD.139 Accordingly, Texas law enforcement and employers are currently experiencing the same
heightened burden for drug testing.

130

An Analysis of Employer Drug Testing in the United States, AM. ADDICTION CTRS.,
https://americanaddictioncenters.org/learn/analysis-employer-drug-testing/ (last visited on Oct. 26, 2020).
131
See Establishment of a New Drug Code for Marihuana Extract, 81 Fed. Reg. 90,194, 90,195 (Dec. 14, 2016)
(codified at 21 C.F.R. § 1308.11(d)) (in the comments to the proposed rule, the DEA states, “Although it might be
theoretically possible to produce a CBD extract that contains absolutely no amounts of other cannabinoids, the DEA
is not aware of any industrially-utilized methods that have achieved this result.”).
132
Kathleen Harvey, Protecting Medical Marijuana Users in the Workplace, 66 CASE W. RES. L. REV. 209, 215
(2015).
133
Anne M. Rector, Use and Abuse of Urinalysis Testing in the Workplace: A Proposal for Federal Legislation
Limiting Drug Screening, 35 EMORY L.J. 1011, 1019–20 (1986).
134
Id. at 1020.
135
See Scott Friedman & Jack Douglas Jr., His Back Hurt So He Tried CBD – It Cost Him His Job, NBC DALLASFORT WORTH (Sept. 23, 2019), https://www.nbcdfw.com/investigations/His-Back-Hurt-So-He-Tried-CBD----ItCost-Him-His-Job-561139041.html.
136
See generally Mitch Mitchell, Don’t Get Lost in the Weeds. Using Legal CBD Products in Texas Could Cost You
a Job, FORT WORTH STAR-TELEGRAM (Sept. 19, 2019), https://www.star-telegram.com/news/business/article23497
2167.html.
137
Id.; see Friedman & Douglas, supra note 135.
138
See id.
139
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V. Employment Protection
This Part highlights relevant provisions of the ADA and its state counterpart, the Texas Labor
Code, to fully illustrate the requirements that employees and applicants must meet in order to
ensure employment protection, in addition to the type of drug policies employers may impose on
their employees. This Part describes the tension between cannabis use and the ADA—specifically,
the effect of marijuana usage on an employee’s ability to implicate protection under either the
ADA or Texas state employment laws. However, the primary focus of this Part is the current lack
of CBD regulation, the FDA’s position regarding CBD products, and possible employment
protection for users of CBD who inadvertently test positive for THC. By evaluating these factors
in totality, this Part emphasizes the current precariousness of employee protection and employer
prohibitions in the wake of H.B. 1325.

A. Federal
The Americans with Disabilities Act (ADA) provides protection against employment
discrimination at the federal level.140 Congress enacted the ADA to establish and enforce standards
that eliminated employment-based discrimination against individuals with disabilities.141 The Act
defines “disability” as “a physical or mental impairment that substantially limits one or more major
life activities of an individual, a record of such impairment, or an individual who is regarded as
having such an impairment.”142 The statute provides examples of such major life activities, such
as “hearing, seeing, sitting, standing, eating, thinking, and communicating.”143
A person claiming that they have such an impairment must demonstrate that they have been subject
to an action prohibited under the ADA because of an actual or perceived impairment, regardless
of whether the impairment limits or is perceived to limit a major life activity.144 The claimed
impairment must last or be expected to last at least six months.145 An impairment that is “episodic
or in remission” must “substantially limit a major life activity when active” in order to qualify
under the ADA.146
The ADA prohibits employment-based discrimination against a qualified individual by a covered
entity with respect to job application procedures, the hiring, advancement, or termination of
140

Elisa Y. Lee, An American Way of Life: Prescription Drug Use in the Modern ADA Workplace, 45 COLUM. J.L.
& SOC. PROBS. 303, 304 (2011) (“Congress passed the Americans with Disabilities Act . . . which expanded the
scope of civil rights protections for individuals with disabilities . . . .”).
141
See 42 U.S.C. § 12101 (2012).
142
42 U.S.C.A § 12102(1) (2009).
143
Id. § 12102(2).
144
Id. § 12102(3)(A).
145
Id. § 12102(3)(B).
146
Id. § 12102(4)(D).
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employees, compensation, job training, and other terms of employment.147 Such “qualified
individuals” are those who, with or without reasonable accommodation, can perform the essential
job functions of the position at issue.148 A “covered entity” is defined as an “employer,
employment agency, labor organization, or joint-labor management committee.”149
The statute defines an “employer” as a person who participates in an industry that affects
commerce and has at least fifteen employees, excluding “United States government-owned
corporations and bona fide private membership clubs.”150 A covered entity is not obligated to
accommodate disabilities without an employee’s request or if doing so would pose an undue
hardship upon the employer.151 If an employee requests a reasonable accommodation, the covered
entity may require documentation before granting it.152 Additionally, a covered entity may not ask
job applicants about the “existence, nature or severity of a disability.”153
The ADA defines the “illegal use of drugs” as the “use of drugs considered unlawful under the
Controlled Substances Act,” but excludes the use of a drug “taken under supervision by a licensed
health care professional or other uses authorized by the Controlled Substances Act.”154 The ADA
allows covered entities to entirely prohibit the use of illegal drugs and alcohol at the workplace or
prohibit employees from being under the influence of drugs and alcohol at the workplace.155
Covered entities are required to provide notice of policies to applicants and employees.156
The ADA does not protect an otherwise qualified individual with a disability who currently uses
illegal drugs, “when the covered entity acts on the basis of such use.”157 Therefore, if an employer
discriminates against a qualified individual with a disability, the ADA will not protect that
individual if the discriminatory act is based on the individual’s use of illegal drugs pursuant to the
CSA.158 However, the ADA does protect individuals who are mistakenly regarded as using drugs
but are not in fact doing so.”159 Interestingly, this language indicates that the ADA formulated an
exception for individuals who could disprove allegations of illegal drug use, long before the
enactment of the Farm Bill. Theoretically, if an individual can prove that his alleged marijuana
use was in fact CBD, the ADA’s exception would apply—particularly because the ADA’s scope
is limited to the CSA, not the Farm Bill or state-approved uses.160
147

Id. § 12112(a).
Id. § 12111(8).
149
Id. § 12111(2).
150
Id. § 12111(5).
151
Facts about the Americans with Disabilities Act, EEOC, https://www.eeoc.gov/eeoc/publications/fs-ada.cfm (last
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See Templeton v. Neodata Servs., Inc., 162 F.3d 617, 619 (10th Cir. 1998) (holding that employee’s failure to
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See Facts, supra note 151.
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Id. § 12115.
157
Id. § 12114(a).
158
Id.
159
Id. § 12114(b)(3).
160
Id.
148

16
Health Law & Policy Brief • Volume 15
Issue 1 • Winter 2020

B. Texas
Texas state law prohibits disability-based employment discrimination pursuant to Chapter 21 of
the Texas Labor Code.161 Chapter 21 is consistent with many ADA provisions and contains similar
language.162 However, there are differences between Chapter 21 and the aforementioned ADA
provisions.163
Chapter 21 follows the ADA standard by withholding protection against employment-based
discrimination for an individual who “currently uses or possesses a controlled substance as defined
in Schedules I and II of . . . the Controlled Substances Act.”164 It similarly carves out an exception
for authorized use of a prohibited Schedule I drug.165 However, it also inadvertently broadens the
scope of protection to include Schedule II drugs authorized by a health care professional “or
otherwise authorized by the [CSA] or any other federal or state law.”166
While the Texas statute deviates from the ADA by permitting the authorized use of a wider scope
of drugs and allowing laws other than the CSA to define illegal drugs, it mirrors the ADA in its
lack of protection for individuals who test positive for THC because Texas has not decriminalized
marijuana.167 Therefore, for purposes of CBD use, Chapter 21 reflects the requirements of the
ADA in order for a CBD user to invoke its protection.168 So long as an individual can prove the
substance in question does not contain THC, they may invoke protection against discrimination
pursuant to Chapter 21.

C. Cannabis Use
As marijuana is currently prohibited as a Schedule I controlled substance under the CSA, the ADA
will not protect an individual who uses marijuana.169 Therefore, an otherwise qualified individual
may not bring a claim under the ADA for discrimination based on medical marijuana use, even in
a state that has decriminalized such use.170 While the ADA offers marijuana users no protection,

161

TEX. LAB. CODE ANN. § 21.001(4) (West 2019).
El Paso v. Vasquez, 508 S.W.3d 626, 637 (Tex. App. 2016).
163
See generally id. at 641 (“We cannot conclude that Chapter 21 [of the Texas Labor Code] and the ADA are
analogous for purposes of creating a disclosure of confidential health information cause of action.”).
164
TEX. LAB. CODE ANN. § 21.120(a).
165
Id.
166
Id.
167
Compare 42 U.S.C.A. §12114(a)–(b), with TEX. LAB. CODE ANN. § 21.120(a).
168
Compare 42 U.S.C.A. §12114(a)–(b), with TEX. LAB. CODE ANN. § 21.120(a).
169
21 U.S.C. § 812(c) (1970); 42 U.S.C.A. § 12111(6)(a).
170
See generally 21 U.S.C. § 812(c); 42 U.S.C.A. §12111(6)(a).
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employees may find relief through enforcement of state laws.171 Courts have generally held that
while marijuana is federally prohibited, state laws authorizing the use of marijuana are not
federally preempted.172
Questions regarding employment rights and CBD-based products surfaced following the passage
of the 2018 Farm Bill.173 Many employers are now uncertain whether the legalization of hempderived products will affect their ability to enforce drug policies; employees are unsure what their
rights will be regarding CBD use and whether the ADA will protect such rights.174 In Texas, H.B.
1325 amplifies these questions.175
Following the 2018 Farm Bill’s declassification of hemp as a controlled substance, the ADA
exception for individuals who engage in illegal drug use does not apply to those using CBD.176
Therefore, the ADA would presumably protect an otherwise qualified individual who uses CBD
to ameliorate a disability.177 At the same time, a caveat remains: the substance may not contain
more than 0.3% THC.178 This poses further complications due to the lack of regulation regarding
CBD products, coupled with stringent FDA restrictions on current products.179
1. Unregulated CBD Concentrations
As hemp-derived CBD is not yet regulated, CBD concentrations in consumer products lack
standardization.180 For purposes of federal and Texas state law, hemp-derived products are merely
required to contain less than 0.3% THC.181 There is no standard for CBD concentration.182
Consumers and regulators alike have no method of discerning just how much CBD a product
contains. Companies face legal challenges both with the FDA and in courts due to inconsistency
between claimed and actual levels of CBD.183 Therefore, consumers lack both actual knowledge
171

See Wild v. Carriage Funeral Holdings, Inc., 205 A.3d 1144, 1147 (N.J. Super. Ct. App. Div. 2019) (holding that
although the New Jersey Compassionate Use Act refused to require employment accommodations for users of
medical marijuana, employers were not immunized from such requirements imposed elsewhere).
172
See Barbuto v. Advantage Sales & Mktg., LLC, 78 N.E.3d 37, 45 (Mass. 2017); In re D.M., 444 P.3d 834, 837
(Colo. App. 2019).
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See generally Lisa L. Gill, Can You Take CBD and Pass a Drug Test?, CONSUMER REPORTS (May 15, 2019),
https://www.consumerreports.org/cbd/can-you-take-cbd-and-pass-a-drug-test/.
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See id.
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See Friedman & Douglas Jr. supra note 135.
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U.S.C.A. 42 § 12114(a) (West 2009); see id. § 12111(6)(a); supra text accompanying notes 99–101.
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See § 12114(a).
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Agricultural Improvement Act of 2018 § 297A, 7 U.S.C. § 1639o(1) (2018).
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See generally Cindy Krischer Goodman, Buyer Beware: CBD Products Could Be This Century’s Snake Oil, S.
FLA. SUN SENTINEL (Jun. 07, 2019), https://www.sun-sentinel.com/health/fl-ne-cbd-regulation-201906074upiw7zacfgt5k24glrvxqiswu-story.html (discussing the CBD industry’s lack of regulations and resulting concerns).
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Grinspoon, supra note 12.
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Agricultural Improvement Act § 297A; H.R. 1325, 86th Leg., Reg. Sess. (Tex. 2019).
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Grinspoon, supra note 12.
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See Warning Letters and Test Results for Cannabidiol-Related Products, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products
(last updated Aug. 20, 2020). See generally Horn v. Med. Marijuana, Inc., 383 F. Supp. 3d 114, 122 (W.D.N.Y.
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of what they are consuming and clarity regarding drug-testing results. Although CBD products
are required to contain less than 0.3% THC, there is no guarantee of compliance.184
The inability to discern CBD content has led to inconsistency in labeled dosages of CBD
products.185 A 2017 scientific study found that about seventy percent of CBD products sold online
were incorrectly labeled, with twenty-six percent of the products containing a lower CBD
concentration than the labeled dosage indicated.186 In addition to the mislabeling of CBD
concentration, a number of the tested products contained a mean of 1.18% THC—a concentration
high enough to produce psychoactive effects, and that exceeds the federal- and state-mandated
limit.187 For consumers, this entails the possibility that lawful purchase and use of a CBD product
could result in a positive drug test, in addition to potentially severe health effects, such as adverse
reactions with other drugs or abnormalities in the liver.188
The lack of CBD regulation implicates consumers’ inability to ensure safety even if they adhere
to the stipulations of the law. The uncertainty of CBD concentration in products means that there
is currently no consistent answer for drug testing: will a person test positive for THC, even if he
purchases a CBD product under the assumption that it does not contain THC? If such a product is
CBD isolate, then the answer is likely no.189 On the other hand, full-spectrum CBD is generally
regarded as more effective than CBD isolate because of the “entourage effect” in which the
different cannabinoids work together to increase effectiveness of the substance.190
Thus, consumers are likely to opt for full-spectrum CBD and run the risk of ingesting more THC
than they had expected, based on the information on the product label.191 Such risk is compounded
when considered in combination with how THC may appear in a urinalysis test up to thirty days
after initial use and in a hair analysis test for up to ninety days after initial use.192 While some
authorities have stated that any THC present in CBD products would be minimal and unlikely to
2019) (plaintiff employees relied on a CBD product’s claim of zero percent THC concentration and subsequently
failed drug tests, resulting in termination).
184
See Horn, 383 F. Supp. 3d at 129 (“Defendant’s own testing revealed that the product contained detectible
amounts of THC.”).
185
Marcel O. Bonn-Miller et al., Labeling Accuracy of Cannabidiol Extracts Sold Online, 318 JAMA 1708, 1708
(Nov. 7, 2017), https://jamanetwork.com/journals/jama/fullarticle/2661569.
186
Id.
187
Id.
188
Marilyn A. Huestis et. Al., Cannabidiol Adverse Effects and Toxicity, 17 CURRENT NEUROPHARMACOLOGY 974,
975, 977, 981 (2019) (stating that CBD pharmacology has the potential for adverse effects and drug-drug
interactions, including toxicity and increased liver function). See generally Bonn-Miller et al., supra note 185.
189
See generally Carter & Vandergriendt, supra note 32 (stating that CBD isolate does not contain additional
compounds and therefore should not contain THC).
190
What Does Full Spectrum Mean?, EXTRACT LABS (July 31, 2019), https://www.extractlabs.com/cbdguides/what-does-full-spectrum-mean/.
191
See generally id.
192
Scott E. Hadland and Sharon Levy, Objective Testing – Urine and Other Drug Tests, 25 CHILD & ADOLESCENT
PSYCHIATRIC CLINICS N. AM. 549 tbl.1 (July 2016).
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cause a positive drug test, the current lack of regulation breeds uncertainty regarding actual THC
content, and thus implicates the possibility of positive drug test results.193 In light of H.B. 1325,
Texas employers now must contend with such uncertainty as CBD products enter the state market
without regulation.
2. FDA Restrictions
Congress explicitly reserved the authority to regulate products containing cannabis and cannabisderived substances (cannabis-derived products) to the Food and Drug Administration in the 2018
Farm Bill.194 The FDA therefore is responsible for enforcing the law as well as establishing
regulations for cannabis-derived products.195 The FDA holds cannabis-derived products to the
same requirements as other FDA-regulated products.196 The agency requires cannabis-derived
products that are marketed with a therapeutic benefit claim or disease claim197 to obtain FDA
approval for their intended use before entering interstate commerce.198
The FDA defines a “dietary supplement” as a “product . . . intended to supplement the diet that
bears or contains one or more” of a specified list of dietary ingredients.”199 In contrast, a “drug”
is defined as an “articles intended for use in the diagnosis, cure, mitigation, or prevention of
disease,” and “articles . . . intended to affect the structure or function of the body.”200 However,
the FDA has explicitly excluded THC and CBD products from the definition of “dietary
supplements.”201 Cannabis-derived products intended for disease-related use are instead
considered new drugs,202 and may not be marketed in the United States without undergoing the
FDA drug approval process for human use.203 Currently, the FDA prohibits the introduction of
food containing added CBD or THC into the market, as well as the marketing of CBD or THC
products as, or as component part of, dietary supplements.204
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In June 2018, the FDA “approved [the drug] Epidiolex . . . for the treatment of seizures associated
with two rare and severe forms of epilepsy.”205 Epidiolex is the first, and currently the sole, FDAapproved drug containing a cannabis-derived substance.206 Presently, the presence of any other
drug, food product, or dietary supplement containing CBD in interstate commerce violates the
Food, Drug, and Cosmetic Act.207 The FDA’s focus, nevertheless, is on the “marketing of CBD
products that make unsubstantiated therapeutic claims” without new drug approval.208 Thus, the
FDA’s main enforcement efforts have primarily constituted the issuance of warning letters to noncompliant sellers of CBD products.209 Although the presence of food and dietary drugs containing
CBD in interstate commerce is currently unlawful, the FDA’s focus is on CBD products that are
marketed with unsubstantiated therapeutic claims.210 As Epidiolex is presently the only FDAapproved cannabis-derived medical treatment on the market, no other drugs containing CBD may
be sold legally.211 The FDA’s demonstrated and enumerated lack of focus on CBD products
without such marketing, however, contributes to the current uncertainty surrounding the actual
benefits and contents of such products.212
3. Effect of Cannabis Use
While the ADA does not protect marijuana users from employment discrimination on the basis of
disability, it may protect CBD users so long as the CBD product does not contain THC.213 A
qualified individual must have a disability, use CBD to ameliorate such a disability, and be able to
provide documentation to that effect.214 The ADA does not specifically require the
accommodation to be a medication.215 Thus, the lack of FDA-approved CBD drugs is unlikely to
bar ADA protection because a qualified individual would presumably be able to use a dietary
supplement or food containing CBD as an accommodation.216 While such products are presently
illegal at the federal level and will likely remain so until the FDA deems otherwise, the ADA only

205

Press Release, U.S. FOOD & DRUG ADMIN., supra note 9.
Id.
207
Hemp Production and the 2018 Farm Bill: Hearing Before the Senate Comm. On Agriculture, Nutrition, &
Forestry, 116th Cong. 11 (2018) (statement of Amy Abernethy, Principal Deputy Comm’r of the Office of the
Comm’r, Food & Drug Admin., U.S. Dep’t of Health & Human Servs.).
208
Id. at 51.
209
Warning Letters and Test Results for Cannabidiol-Related Products, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products
(last updated Oct. 9, 2019).
210
See generally Hemp Production and the 2018 Farm Bill: Hearing Before the Senate Comm. On Agriculture,
Nutrition, & Forestry, supra note 207.
211
Id. at 49.
212
Id. at 54.
213
See generally 42 U.S.C.A. § 12114(a) (West 2009).
214
See id. § 12102(1); Templeton, 162 F.3d at 619 (granting summary judgement to defendant-employer for
Templeton’s failure to produce medical information).
215
§ 12111(9).
216
See generally id.
206

21
The Budding Hemp Industry: The Effect of Texas House Bill 1325 on
Employment Drug Policies
Meina Heydari

excludes illegal drug use as defined by the CSA.217 An employee therefore would likely be able
to implicate the ADA in an employment discrimination dispute.
Conversely, if the CBD contains THC, the issue becomes whether an employee who lawfully uses
a substance to ameliorate his disability but tests positive for a substance that is illegal at both the
state and federal levels, may access employment discrimination protections. The ADA does not
protect medical marijuana users due to the Schedule I classification, even though such use is
permitted in some states.218 Therefore, employees have no federal protection against employment
discrimination if they test positive for THC, regardless of whether they used marijuana or CBD.
Similarly, Texas state laws provide no protection against employment discrimination based on
positive results of a drug test.219 Chapter 21 of the Texas Labor Code allows employers to “[adopt]
a policy prohibiting the employment of an individual who currently uses or possesses a controlled
substance as defined in . . . the Controlled Substances Act . . . other than the use or possession of
a drug taken under the supervision of a licensed health care professional or any other use or
possession authorized by the Controlled Substances Act or any other federal or state law.”220 The
provision may protect CBD users so long as they do not test positive for THC.
As described above, the broadened scope encompassing “any other federal or state law” fails to
provide additional protection because Texas has yet to decriminalize marijuana.221 Additionally,
the Compassionate Use Act does not furnish employment protection for qualifying patients.222
Therefore, Texas state laws mirror federal laws in that they do not provide protection against
employment discrimination for an employee who tests positive for THC.223
In light of the current state of employment discrimination laws, employers may form policies
prohibiting the use of CBD until drug testing equipment advances. Meanwhile, employees should
abstain from using CBD at the risk of testing positive for THC due to the risk that employment
discrimination laws may not apply to them.
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VI. Proposal for Legislative Amendment of H.B. 1325 and Regulatory
Rules
The vague languages of the ADA and Chapter 21 of the Texas Labor Code exacerbate the
confusion surrounding protection of CBD use in the workplace.224 Employers and employees alike
require a clear rule regarding permitted CBD use, particularly in light of the absence of reliable
testing methods and rigorous FDA restrictions.225 This issue will likely increase with time as the
remaining states that have not legalized CBD choose to do so.
Ideally, drug testing equipment will advance such that both law enforcement and employers will
be able to accurately differentiate between marijuana and CBD, thereby eliminating the need to
alter employment protection policies. Employees would then have access to protection under the
ADA and the corresponding Texas Labor Code in the event of a dispute over CBD use.226
Employers would be provided clarification regarding their ability to prohibit CBD use entirely.227
However, such technological advances require extensive funding and time,228 which leaves Texas
civilians and law enforcement without guidance in the interim.229 The best method to ameliorate
the uncertainty that has followed CBD legalization is likely a combination of an amendment to
H.B. 1325 raising the THC threshold, administrative rules requiring third-party verification on
CBD content and state-allocated funding for enforcement, and an exception to the Texas Labor
Code for employees who successfully prove lawful use. 230
The 0.3% THC threshold was established on the basis of Dr. Ernest Small’s research study, in
which the researchers “arbitrarily adopt[ed] a concentration of 0.3% THC . . . as a guide to
discriminating” between hemp and marijuana.231 There is a weak basis for the 0.3% THC
threshold, as it falls quite short from the amount required to produce the psychoactive effects. In
fact, the present definition of hemp was adopted “because [THC] is the only one of at least 113
different biochemical compounds produced in . . . [cannabis] that can have an intoxicating effect
on humans.”232 Thus, the government’s primary concern is preventing THC intoxication.233 While
224
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raising the THC threshold may cause conflict with the federal statute, states are not federally
preempted with respect to authorizing marijuana use.234 Therefore, an amendment to H.B. 1325,
in which the Texas Legislature redefines hemp by raising the THC threshold, would both alleviate
concerns regarding employees working while under the influence as well as preserve the right to
access legal treatment for disabilities.
As cannabis requires a concentration of at least one percent THC to produce a psychoactive
effect,235 raising the permitted concentration from 0.3% to 0.5% would promote flexibility for lawabiding consumers while also accommodating safety interests.236 Due to seasonal fluctuations and
environmental influences, cannabis plants may contain “more or less THC than 0.3% at different
times.”237 Additionally, the Texas Compassionate Use Act allows qualifying patients who suffer
from specified illnesses to use cannabis containing 0.5% THC.238 While the Texas Legislature has
explicitly stated that it will not decriminalize marijuana,239 it may be receptive to increasing the
THC threshold by 0.2%, particularly after evaluating the benefits of doing so. Raising the THC
threshold for CBD would result in more flexibility for lawful users, and a continued absence of
psychoactive effects. However, while the increased threshold provides more flexibility, it does
not in itself solve the issue of the State’s inability to test CBD.
Between 2017 and 2018, fifty-two cases of CBD-related poisoning were reported in Utah.240 In
2018, the Utah Department of Agriculture and Food responded by imposing administrative rules
requiring registration of all hemp products.241 The rules require both manufacturers and
distributors of CBD products to obtain a certificate of analysis of each CBD product from a thirdparty lab.242 The product is then accompanied with a QR code or bar code that links to the
certificate and appears similar to labels for dietary supplements.243 This policy ensures that label
information is verified, and alleviates consumer concerns regarding CBD purity.244 The Utah
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Department of Agriculture and Food has begun working with retail stores to ensure that only
compliant products are available for sale.245
In Texas, the Department of State Health Services oversees CBD regulation.246 By adopting
administrative rules modeled after those in Utah, the Department would transfer the burden of
verifying CBD contents from the State to CBD manufacturers and distributors who seek
participation in the Texas CBD market. The possible bar on participation in the Texas CBD market
would likely incentivize manufacturers, distributors, and private companies to establish labs in
compliance with the administrative rules. The U.S. Census Bureau estimates the Texas population
as of July 2019 at nearly twenty-nine million people,247 making up almost nine percent of the total
United States population.248 In 2019, Texas contributed over eight percent of the total United
States gross domestic product.249 Therefore, CBD manufacturers and distributors face a
substantial incentive to comply with any certificate analysis stipulations mandated by the
Department of Health.
The administrative rules should include a provision requiring Texas legislators to allocate funding
for enforcement. For example, Travis County legislators are currently debating whether to allocate
funding for lab testing due to concerns that arrests for low-level marijuana possessions would
“derail people’s lives.”250 In contrast, Bexar County recently allocated over $100,000 in city funds
to obtain drug testing equipment.251 While such a provision would impose costs on the state, such
costs would likely be mitigated by the burden-shifting mechanism of the verification rules. In
addition, it would likely motivate Texas legislators to allocate funding for lab testing, considering
that CBD sales are projected to surpass twenty billion dollars in the United States by 2024.252
Thus, the adoption of administrative rules modeled after those in Utah, including a provision
requiring funding for enforcement, would likely provide a solution to the current lack of available
testing equipment.
Finally, Chapter 21 of the Texas Labor Code should be amended to include a provision granting
protection for employees who successfully prove that any alleged use of marijuana was actually
245
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use of CBD. Unlike the ADA, Chapter 21 lacks a specific remedy for individuals who were
wrongfully discriminated against on the basis of illegal drug use.253 A specific exception, modeled
after that of the ADA,254 would provide individuals who lawfully used CBD with a procedure by
which to appeal a decision or to combat an allegation of illegal drug use. Therefore, if an individual
uses CBD that has been verified in accordance with the proposed administrative rules but is found
to have contained greater than 0.5% THC, they will nevertheless have an avenue by which to
pursue relief.

VII. Conclusion
CBD use has rapidly risen over the past twenty years, specifically in the wake of the 2018 Farm
Bill.255 At the same time, practical issues such as reliable drug testing equipment and FDA
regulations have yet to be solved, resulting in confusion about what exactly consumers are
ingesting when they purchase CBD products. While CBD currently poses uncertainty at the
federal level, it simultaneously does so at the state level.
By passing H.B. 1325, the Texas Legislature took a step forward in the realm of cannabis
decriminalization while repeatedly emphasizing its disinterest in decriminalizing marijuana,256
forcing its citizens to choose between treating impairments with CBD and ensuring that they test
negative for the presence of drugs.
The government should amend H.B. 1325 to increase the THC threshold to 0.5%, implement rules
requiring third-party verification of CBD purity, allocate state funding for enforcement, and amend
the Labor Code to provide people wrongfully deemed as using illegal drugs with procedure to
appeal such findings. By implementing these policies, the Texas government may balance
employers’ safety concerns with employees’ rights to access treatment without fear of
discrimination.
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